Doi.org/10.1158/1538-7445.AM2015-408
Target ArticleEdit
ACP-196, An Orally Bioavailable Covalent Selective Inhibitor of Btk, Modulates the Innate Tumor Microenvironment, Exhibits Antitumor Efficacy and Enhances Gemcitabine Activity in Pancreatic Cancer ; Brian J Lannutti Michael Gulrajani Fanny Krantz Elena Bibikova Todd Covey Katti Jessen Wayne R; NULL; 08/02/2015; https://doi.org/10.1158/1538-7445.AM2015-408
ReasonsEdit
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.